DK0831938T3 - Radiomærkede peptidsammensætninger til stedspecifik målsögninger - Google Patents

Radiomærkede peptidsammensætninger til stedspecifik målsögninger

Info

Publication number
DK0831938T3
DK0831938T3 DK96922403T DK96922403T DK0831938T3 DK 0831938 T3 DK0831938 T3 DK 0831938T3 DK 96922403 T DK96922403 T DK 96922403T DK 96922403 T DK96922403 T DK 96922403T DK 0831938 T3 DK0831938 T3 DK 0831938T3
Authority
DK
Denmark
Prior art keywords
somatostatin
peptide
radiolabeled peptide
radiolabeled
site
Prior art date
Application number
DK96922403T
Other languages
Danish (da)
English (en)
Inventor
Ananthachari Srinivasan
Joseph E Bugaj
Mary Marmion Dyszlewski
Jack L Erion
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23907713&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0831938(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of DK0831938T3 publication Critical patent/DK0831938T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK96922403T 1995-06-07 1996-06-06 Radiomærkede peptidsammensætninger til stedspecifik målsögninger DK0831938T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/480,373 US5830431A (en) 1995-06-07 1995-06-07 Radiolabeled peptide compositions for site-specific targeting
PCT/US1996/009384 WO1996040291A1 (fr) 1995-06-07 1996-06-06 Compositions de peptides radiomarques pour le ciblage specifique d'un site

Publications (1)

Publication Number Publication Date
DK0831938T3 true DK0831938T3 (da) 2008-07-21

Family

ID=23907713

Family Applications (2)

Application Number Title Priority Date Filing Date
DK96922403T DK0831938T3 (da) 1995-06-07 1996-06-06 Radiomærkede peptidsammensætninger til stedspecifik målsögninger
DK07019899.9T DK1872800T3 (da) 1995-06-07 1996-06-06 Radiomærkede peptidsammensætninger til stedsspecifik målsøgning

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK07019899.9T DK1872800T3 (da) 1995-06-07 1996-06-06 Radiomærkede peptidsammensætninger til stedsspecifik målsøgning

Country Status (10)

Country Link
US (2) US5830431A (fr)
EP (2) EP1872800B1 (fr)
JP (2) JP4236282B2 (fr)
AT (1) ATE395938T1 (fr)
CA (1) CA2224153C (fr)
DE (1) DE69637535D1 (fr)
DK (2) DK0831938T3 (fr)
ES (2) ES2308778T3 (fr)
PT (1) PT831938E (fr)
WO (1) WO1996040291A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
MY133346A (en) * 1999-03-01 2007-11-30 Biogen Inc Kit for radiolabeling ligands with yttrium-90
US20020102208A1 (en) 1999-03-01 2002-08-01 Paul Chinn Radiolabeling kit and binding assay
US6358491B1 (en) 1999-08-27 2002-03-19 Berlex Laboratories, Inc. Somatostatin analogs
US7067111B1 (en) * 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
EP1286704B1 (fr) 2000-06-02 2014-07-23 Board of Regents, The University of Texas System CONJUGUES D'ETHYLENEDICYSTEINE (EC) ET D'UN analogue de la glucose, COMPOSITIONS ET PROCEDES POUR L'IMAGERIE DE MALADIES A SPECIFICITE TISSULAIRE
US20020197261A1 (en) * 2001-04-26 2002-12-26 Chun Li Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use
US7261875B2 (en) * 2001-12-21 2007-08-28 Board Of Regents, The University Of Texas System Dendritic poly (amino acid) carriers and methods of use
US20040166058A1 (en) * 2002-11-07 2004-08-26 Board Of Regents, The University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
CA2518406A1 (fr) * 2003-03-10 2004-09-23 Biogen Idec Ma Inc. Fixation de medicament a mediation de thiol a des peptides de ciblage
US9050378B2 (en) * 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
EP1861127A1 (fr) * 2005-03-10 2007-12-05 Bayer Schering Pharma Aktiengesellschaft Chelateurs pour des conjugues radioactivement marques comprenant une chaine laterale stabilisante
US8758723B2 (en) * 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
WO2011075678A1 (fr) 2009-12-18 2011-06-23 The Board Of Trustees Of The Leland Stanford Junior University Inhibiteurs spécifiques et sondes de site actif pour la légumaïne
US8791121B2 (en) 2010-08-12 2014-07-29 New York University Oligooxopiperazines and methods of making and using them
JP2015508779A (ja) 2012-02-16 2015-03-23 ニューヨーク・ユニバーシティ 低酸素状態で誘導可能な遺伝子発現の、オリゴオキソピペラジン非ペプチド性へリックス模倣体による制御
US10994032B2 (en) 2012-05-08 2021-05-04 Trt Innovations Aps 177-Lu labeled peptide for site-specific uPAR-targeting
CN108137690A (zh) 2015-06-25 2018-06-08 高级催化剂应用品有限公司 治疗过度表达生长抑素受体的神经内分泌肿瘤的方法
EP3568205B1 (fr) 2017-01-12 2023-08-16 Radiomedix Inc. Traitement de cellules cancéreuses exprimant recepteurs de la somatostatine en excès avec des dérivés de l'octréotide chelé avec des radioisotopes
US10596278B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
US10596276B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
US11357874B2 (en) 2018-09-11 2022-06-14 Stanley Satz Tumor targeted radionuclide therapy and molecular imaging of HER2+ cancers and other neoplasms

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3062075D1 (en) * 1979-11-27 1983-03-24 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
US4282143A (en) * 1980-06-13 1981-08-04 American Home Products Corporation Octapeptides lowering growth hormone
US4440904A (en) * 1983-01-31 1984-04-03 American Home Products Corporation Nonapeptide anti-secretory agents
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
GB9111199D0 (en) * 1991-05-23 1991-07-17 Sandoz Ltd Improvements in or relating to organic compounds
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
JPH04236282A (ja) * 1991-01-18 1992-08-25 Aica Kogyo Co Ltd 接着剤組成物
EP0600992B1 (fr) * 1991-08-29 2000-09-20 Mallinckrodt Medical, Inc. Utilisation de l'acide gentisique ou de l'alcool gentisyle pour stabiliser des peptides et proteines radiomarques
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
US5411943A (en) * 1992-02-25 1995-05-02 Biomeasure, Inc. Hepatoma treatment with somatostatin analogs
CA2113121A1 (fr) * 1993-01-12 1994-07-13 Rainer Albert Peptides
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
CA2168113C (fr) * 1993-08-09 2002-10-01 Sun Hyuk Kim Derives de peptides, agents therapeutiques
WO1995013832A1 (fr) * 1993-11-16 1995-05-26 Resolution Pharmaceuticals Inc. Procede de marquage fixe
WO1995019187A1 (fr) * 1994-01-12 1995-07-20 Amersham International Plc Agents biologiques de ciblage
EP0835662B1 (fr) * 1996-10-08 2001-11-14 National Institute of Immunology Médicament pour le traitement du cancer

Also Published As

Publication number Publication date
CA2224153A1 (fr) 1996-12-19
DE69637535D1 (de) 2008-07-03
EP1872800A3 (fr) 2008-03-19
EP0831938A4 (fr) 2001-12-05
US5830431A (en) 1998-11-03
ES2395961T3 (es) 2013-02-18
JP2008266342A (ja) 2008-11-06
WO1996040291A1 (fr) 1996-12-19
US5804157A (en) 1998-09-08
CA2224153C (fr) 2010-08-17
ATE395938T1 (de) 2008-06-15
JP4236282B2 (ja) 2009-03-11
EP1872800B1 (fr) 2012-10-17
EP0831938B1 (fr) 2008-05-21
DK1872800T3 (da) 2013-02-04
PT831938E (pt) 2008-08-26
ES2308778T3 (es) 2008-12-01
EP1872800A2 (fr) 2008-01-02
JPH11507342A (ja) 1999-06-29
EP0831938A1 (fr) 1998-04-01

Similar Documents

Publication Publication Date Title
DK0831938T3 (da) Radiomærkede peptidsammensætninger til stedspecifik målsögninger
Gregory et al. The primary structure of human urogastrone
ATE314097T1 (de) Kontrastmittel
BG103522A (en) Compositions and methods for ob type protein syntheses
ATE113063T1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
DK0762901T3 (da) Technetium-99m-mærkede peptider til imagografi
WO1998018497A3 (fr) Agents de contraste
ATE254138T1 (de) An den erythropoietin-rezeptor bindende zusammensetzungen und peptide
DK1565212T3 (da) Gastrinsammensætninger og formuleringer, og fremgangsmåde til anvendelse og fremstilling
ATE321774T1 (de) An aminosaeure angereicherte speicherproteine, insbesondere an lysin angereicherte mais-gamma- zeine, und diese exprimierende pflanzen
WO2000005249A3 (fr) Peptides synthetiques et procedes d'utilisation de ceux-ci dans des therapies de maladies auto-immunes
CA2303395A1 (fr) Traitement de l'obesite
CA2439598C (fr) Peptide modifie
EP1279677A4 (fr) Peptides gd3 mimetiques
PT1095143E (pt) Inibidor para o diagnóstico e tratamento de doentes com hemofilia a
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
DK0811068T3 (da) Humane DNase I varianter
Pinas et al. Synthesis and biological properties of the [5-(N5-dimethyl)-glutamine]-analogue of the C-terminal heptapeptide of substance p: Active-site studies
Lee et al. Solid-phase edman degradation: A new method for attaching peptides to insoluble resins using trifluoroacetic anhydride
WO2003092744A3 (fr) Compose peptidique presentant une meilleure affinite de liaison avec les recepteurs de la somatostatine
ATE276273T1 (de) Vip-analoge
MX9706429A (es) Variantes de dnasa i humana.